JBS Stocks Fall 4.00% as Third-Quarter Adjusted EBITDA Drops 36%

JBS shares dropped 4.00% to $12.60 after reporting a 36% decline in third-quarter adjusted EBITDA to $1.18 billion, with net income falling to $164 million. Net sales remained flat at $22.7 billion, and free cash flow turned negative at $167 million. The company cited weaker beef markets and lower China exports for the results, according to TheStreet.

Original reporting
Published Nov 10, 2026, 6:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 7:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JBS Stocks Fall 4.00% as Third-Quarter Adjusted EBITDA Drops 36% — source image
Decision brief

The 30-second read

$JBSBearishHigh
01

Why it matters

The 36% EBITDA decline and 4% share fall suggest heightened risk for the stock in the near term.

02

Market read

JBS earnings miss adds downside pressure to the meat sector and may influence related commodity pricing.

03

What to watch

China's 2027 quota expectations and seasonal beef demand could mitigate the earnings shortfall.

Relevance 8/10Novelty 8/10Timing: pre-market today

Background

JBS is the world's largest meat processor, and its quarterly performance is closely watched by commodity and agribusiness investors.

Company-level read

Ticker impact

$JBSBearishHigh confidence
Context

JBS reported Q3 adjusted EBITDA down 36% and a 4% share drop, marking the first public disclosure of its quarterly results.

Expected impact

likely further downside as investors price in weaker beef margins and lower China exports.

Evidence & confidence

The report shows a sharp earnings decline, negative free cash flow, and higher leverage, all fresh data that typically trigger sell pressure.

Market effects

Beef and meat processing sector may face broader scrutiny as margins tighten.

U.S. agribusiness stocks could see modest pullback.

Potential ripple to commodity markets if China import quotas stay constrained.

Counterpoint

If inventory builds and margins recover in Q4, the stock could rebound despite the Q3 miss.

Key entities

  • JBS

    Global meat processing firm listed on NYSE.

Related articles

$JBSHighAI 9/10

JBS (JBS) Q3 2026 Earnings Call Transcript

JBS reported Q3 2026 net sales of $22.7B (+1% YoY) and adjusted EBITDA of $1.2B (5.2% margin). Adjusted net income fell to $167M from $595M YoY. JBS USA Beef returned to profitability, while pork and poultry segments faced margin pressures. The company plans to reduce 2027 CapEx by $500M and aims for net leverage below 3x by 2027. Management highlighted the Flora acquisition and anticipated Australian asset sale proceeds of $800M.

$JBSMed

What JBS (JBS) Said on Its Q3 Earnings Call

JBS reported Q3 earnings, noting improved U.S. cattle supply but challenging pork conditions. Brazilian beef business Friboi redirected exports due to China's reduced demand. Seara faced higher costs and expects Q4 margin improvement. JBS acquired Flora for $442M and Canal Rural for $16M, plans to reduce 2027 capital spending by $500M. Management expects leverage to remain stable in 2026 and potentially decrease in 2027.

$JBSHighAI 8/10

JBS Profit Hit as China Quotas Overshadow US Beef Improvement

JBS NV reported a 71% drop in adjusted earnings to 15 cents per share in Q3, as China's beef import quotas and other trade disruptions impacted its Brazilian and Australian units. US beef business showed improvement, with adjusted losses narrowing. The company also announced a $542M deal to acquire full ownership of cosmetics business Flora from its controlling shareholder.

$JBSMed

JBS US Beef Margins Turn Positive as Tyson Cuts Capacity

JBS's North American beef business returned to positive margins in September, with Ebitda margin reaching 3.9%. The turnaround was driven by resumed cattle imports and capacity cuts by Tyson. Adjusted Ebitda fell 36% to $1.2B, net income dropped 72%. CEO Gilberto Tomazoni expressed optimism. China trade reopening and poultry improvements may further support recovery.